MoneyWorks4Me

An increase of about 336.32% to Rs. 235.22 millions in the total revenue was observed for the quarter ended June 2026. The total revenue was pegged at Rs. 53.91 millions during the similar quarter previous year.Net Profit for the quarter ended June 2026 zoomed to 1360.64% from Rs. 10.29 millions to Rs. 150.30  millions.OP of the company witnessed a marginal growth to 217.46 millions from 24.28 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 235.22 53.91 336.32 235.22 53.91 336.32 567.06 325.87 74.01
Other Income 5.40 11.10 -51.35 5.40 11.10 -51.35 45.85 42.07 8.99
PBIDT 217.46 24.28 795.63 217.46 24.28 795.63 333.09 169.36 96.68
Interest 4.30 2.68 60.45 4.30 2.68 60.45 10.93 5.95 83.70
PBDT 213.16 21.60 886.85 213.16 21.60 886.85 322.16 163.41 97.15
Depreciation 10.74 7.87 36.47 10.74 7.87 36.47 34.43 30.05 14.58
PBT 202.42 13.73 1374.29 202.42 13.73 1374.29 287.73 133.36 115.75
TAX 52.12 3.44 1415.12 52.12 3.44 1415.12 67.26 37.62 78.79
Deferred Tax 0.44 -0.62 -170.97 0.44 -0.62 -170.97 -22.19 1.38 -1707.97
PAT 150.30 10.29 1360.64 150.30 10.29 1360.64 220.47 95.74 130.28
Equity 437.88 437.88 0.00 437.88 437.88 0.00 437.88 437.88 0.00
PBIDTM(%) 92.45 45.04 105.27 92.45 45.04 105.27 58.74 51.97 13.02
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..